To amend the Federal Food, Drug, and Cosmetic Act with respect to cellular therapies.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Colorado's 6th congressional district. Republican.
Last Updated: Mar 16, 2016
Length: 9 pages
Mar 16, 2016
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on March 16, 2016, in a previous session of Congress, but was not enacted.
Mar 16, 2016
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 4762 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2018). H.R. 4762 — 114th Congress: REGROW Act. Retrieved from https://www.govtrack.us/congress/bills/114/hr4762
“H.R. 4762 — 114th Congress: REGROW Act.” www.GovTrack.us. 2016. September 22, 2018 <https://www.govtrack.us/congress/bills/114/hr4762>
REGROW Act, H.R. 4762, 114th Cong. (2016).
|title=H.R. 4762 (114th)
|accessdate=September 22, 2018
|author=114th Congress (2016)
|date=March 16, 2016
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.